The fraud investigations of Bristol-Myers Squibb and the University of Medicine and Dentistry of New Jersey posed a dilemma for U.S. Attorney Christopher Christie: how to enforce the law without putting them out of business. Christie chose deferred prosecution, which is relatively new terrain in white-collar cases. Perhaps that's one reason why his deferred prosecutions came under fire at an ABA symposium for what was called excessive prosecutorial involvement in business operations.
Font Size: 
Deferred White-Collar Prosecutions: New Terrain, Few Signposts
New Jersey Law Journal
April 11, 2006
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.
